CRIS Current Research Information System

GIONCHETTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.716
AS - Asia 9.938
EU - Europa 8.943
AF - Africa 811
SA - Sud America 804
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 6
Totale 33.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.529
SG - Singapore 3.222
CN - Cina 2.793
GB - Regno Unito 1.958
IT - Italia 1.836
VN - Vietnam 1.731
DE - Germania 1.176
SE - Svezia 1.055
HK - Hong Kong 880
BR - Brasile 603
RU - Federazione Russa 564
IN - India 509
UA - Ucraina 440
IE - Irlanda 404
FR - Francia 388
KR - Corea 303
NL - Olanda 259
CI - Costa d'Avorio 205
ZA - Sudafrica 175
TG - Togo 174
SC - Seychelles 163
FI - Finlandia 154
CH - Svizzera 141
JP - Giappone 140
BG - Bulgaria 138
EE - Estonia 130
JO - Giordania 117
AR - Argentina 100
CA - Canada 78
BE - Belgio 71
ID - Indonesia 52
AT - Austria 50
PL - Polonia 50
ES - Italia 38
MX - Messico 38
HN - Honduras 37
IR - Iran 32
GR - Grecia 29
BD - Bangladesh 27
EC - Ecuador 27
NG - Nigeria 25
CD - Congo 24
CL - Cile 20
CO - Colombia 19
BZ - Belize 17
PY - Paraguay 17
IQ - Iraq 16
TR - Turchia 15
UZ - Uzbekistan 14
LT - Lituania 12
AU - Australia 11
CZ - Repubblica Ceca 11
KZ - Kazakistan 11
RO - Romania 10
AZ - Azerbaigian 9
MY - Malesia 9
HR - Croazia 8
KE - Kenya 8
LB - Libano 8
VE - Venezuela 8
EG - Egitto 7
PH - Filippine 7
TN - Tunisia 7
MA - Marocco 6
TW - Taiwan 6
BO - Bolivia 5
PK - Pakistan 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AE - Emirati Arabi Uniti 4
IL - Israele 4
PE - Perù 4
DK - Danimarca 3
DZ - Algeria 3
JM - Giamaica 3
NO - Norvegia 3
PT - Portogallo 3
AG - Antigua e Barbuda 2
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
Totale 33.207
Salva come PNG Salva come JPEG
Città #
Singapore 2.096
Southend 1.642
Ashburn 1.449
Fairfield 1.282
Chandler 1.042
Hong Kong 873
Hefei 704
Santa Clara 633
Woodbridge 616
Seattle 539
Wilmington 538
Houston 534
Princeton 514
Dong Ket 444
Cambridge 419
Beijing 412
Dublin 404
Bologna 356
Ann Arbor 353
Boardman 319
Ho Chi Minh City 314
Seoul 290
Hanoi 258
Jacksonville 242
Abidjan 205
Nanjing 197
Los Angeles 177
Lomé 174
Westminster 174
Berlin 168
Padova 153
Milan 144
New York 144
Sofia 133
Tokyo 124
Buffalo 122
Bern 121
Amman 117
Helsinki 111
San Diego 105
Frankfurt am Main 104
Dallas 100
Redondo Beach 87
Jinan 79
Bengaluru 78
Turin 77
Saint Petersburg 76
Shenyang 76
Rome 67
Changsha 66
Guangzhou 66
Brescia 65
Hebei 60
Munich 60
São Paulo 59
Phoenix 58
Nuremberg 53
Mülheim 51
Yubileyny 51
Brussels 50
Redwood City 50
Falkenstein 48
Nanchang 48
Chicago 42
Medford 42
Redmond 42
Bremen 41
London 41
Shanghai 41
Florence 37
Tianjin 37
Dearborn 36
Haiphong 34
Henderson 34
Jiaxing 34
Des Moines 33
Falls Church 33
Washington 31
Mahé 29
Montreal 29
Olalla 29
Lappeenranta 27
Zhengzhou 27
Centro 26
Warsaw 26
Atlanta 25
Da Nang 25
Norwalk 25
Amsterdam 24
Brooklyn 24
Ha Long 24
Haikou 24
Poplar 24
Johannesburg 23
Lubumbashi 23
Quận Bình Thạnh 23
Thái Nguyên 23
Jakarta 22
Saint Louis 22
Brierley Hill 21
Totale 21.274
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 571
Ulcerative Colitis 316
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil antibodies in coeliac disease before and after gluten free diet. 278
COVID-19 in IBD: The experience of a single tertiary IBD center 261
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 246
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 220
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 215
Adult attachment and early parental experiences in patients with Crohn’s Disease 212
Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis 211
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 210
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 207
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 206
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 204
Adalimumab in active ulcerative colitis: a "real-life" observational study. 203
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 198
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 197
Infliximab in the treatment of Crohn's disease 192
Attachment and quality of life in patients with inflammatory bowel disease 189
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 188
Medical treatment and management of severe ulcerative colitis 187
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 187
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 184
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 183
High-dose probiotics for the treatment of active pouchitis 183
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 183
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 182
Influence of steroid treatment's duration in patients with active Crohn's disease 181
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 180
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 179
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 179
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 178
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 176
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 173
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 173
Clinical course of microscopic colitis in a single-center cohort study 173
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 172
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. 171
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 171
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 170
Clinical guidelines for the management of pouchitis 170
Management and treatment of distal ulcerative colitis 168
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 166
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 165
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment 165
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 164
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 164
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 164
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 163
Antibiotics and probiotics in treatment of inflammatory bowel disease 163
Implications of antioxidant enzymes in human gastric neoplasms 161
Frequency of NOD2/CARD15 variants in both sporadic and familial cases of Crohn's disease across Italy. An Italian Group for Inflammatory Bowel Disease Study. 160
Oral budesonide in the treatment of chronic refractory pouchitis. 160
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 160
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 159
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts 157
Review article: aminosalicylates for distal colitis 156
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 155
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 154
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 153
Management of inflammatory bowel disease: does rifaximin offer any promises 153
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 153
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 153
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 152
Which therapies are advisable in pouchitis? 151
Role of Biologics in refractory pouchitis 151
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease 151
Role of conventional therapies in the era of biological treatment in Crohn's disease. 151
Probiotics in IBD: A critical review 151
Antimicrobials in the management of inflammatory bowel disease 150
Parental Bonding and Inflammatory Bowel Disease 150
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 149
The role of Budesonide-MMX in active ulcerative colitis. 149
MANAGEMENT OF POUCHITIS 149
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 148
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 147
Sympathetic hyperactivity in patients with ulcerative colitis. 145
Randomized controlled trials in pouchitis 145
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 145
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 144
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 144
Pre-pouch ileitis 143
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 143
Problematic proctitis and distal colitis 143
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 142
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 142
Probiotics, Prebiotics, and Antibiotics in IBD 140
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 140
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 140
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 139
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 139
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 139
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 138
Oral beclomethasone dipropionate in chronic refractory pouchitis 138
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 138
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 138
Implications of the westernized diet in the onset and progression of IBD 137
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 137
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 136
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 136
A current overview of corticosteroid use in active ulcerative colitis 135
Totale 17.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.619
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.117 0 0 0 0 0 172 140 281 312 244 120 848
2021/20224.114 431 114 247 182 332 178 98 227 331 293 1.079 602
2022/20234.892 505 745 248 551 319 387 141 286 898 141 340 331
2023/20241.530 107 237 137 111 125 358 78 91 40 110 60 76
2024/20255.994 296 834 478 382 929 305 447 208 142 408 318 1.247
2025/20267.719 1.385 1.564 1.335 1.084 1.580 771 0 0 0 0 0 0
Totale 34.112